SE0101093D0 - Novel compound for treatment of allergy and asthma - Google Patents
Novel compound for treatment of allergy and asthmaInfo
- Publication number
- SE0101093D0 SE0101093D0 SE0101093A SE0101093A SE0101093D0 SE 0101093 D0 SE0101093 D0 SE 0101093D0 SE 0101093 A SE0101093 A SE 0101093A SE 0101093 A SE0101093 A SE 0101093A SE 0101093 D0 SE0101093 D0 SE 0101093D0
- Authority
- SE
- Sweden
- Prior art keywords
- allergy
- asthma
- treatment
- novel compound
- ige
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
- C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/54—F(ab')2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0101093A SE0101093D0 (sv) | 2001-03-28 | 2001-03-28 | Novel compound for treatment of allergy and asthma |
PCT/SE2002/000636 WO2002079257A1 (en) | 2001-03-28 | 2002-03-28 | Novel compound for treatment of allergy and asthma |
AU2002251624A AU2002251624B8 (en) | 2001-03-28 | 2002-03-28 | Novel compound for treatment of allergy and asthma |
CA2441048A CA2441048C (en) | 2001-03-28 | 2002-03-28 | Novel compound for treatment of allergy and asthma |
US10/108,301 US6986889B2 (en) | 2001-03-28 | 2002-03-28 | Compound for treatment of allergy and asthma |
EP02720698A EP1373322A1 (en) | 2001-03-28 | 2002-03-28 | Novel compound for treatment of allergy and asthma |
JP2002577880A JP2005500992A (ja) | 2001-03-28 | 2002-03-28 | アレルギーおよび喘息の治療用新規化合物 |
US12/757,821 USRE42324E1 (en) | 2001-03-28 | 2010-04-09 | Compound for treatment of allergy and asthma |
JP2013166370A JP2014012683A (ja) | 2001-03-28 | 2013-08-09 | アレルギーおよび喘息の治療用新規化合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0101093A SE0101093D0 (sv) | 2001-03-28 | 2001-03-28 | Novel compound for treatment of allergy and asthma |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0101093D0 true SE0101093D0 (sv) | 2001-03-28 |
Family
ID=20283563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0101093A SE0101093D0 (sv) | 2001-03-28 | 2001-03-28 | Novel compound for treatment of allergy and asthma |
Country Status (7)
Country | Link |
---|---|
US (2) | US6986889B2 (sv) |
EP (1) | EP1373322A1 (sv) |
JP (2) | JP2005500992A (sv) |
AU (1) | AU2002251624B8 (sv) |
CA (1) | CA2441048C (sv) |
SE (1) | SE0101093D0 (sv) |
WO (1) | WO2002079257A1 (sv) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6884877B2 (en) | 2001-10-03 | 2005-04-26 | Florida State University Research Foundation, Inc. | Purified linear epitopes from cashew nuts, nucleic acids encoding therefor, and associated methods |
JP5389442B2 (ja) * | 2005-09-29 | 2014-01-15 | メディミューン,エルエルシー | 膜Ig特異的抗体を同定する方法および免疫グロブリンを生成する前駆体細胞を標的化するための使用 |
US10196458B2 (en) | 2013-07-26 | 2019-02-05 | The Regents Of The University Of California | Anti-immunoglobulin E antibodies and methods of using thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5449760A (en) | 1987-12-31 | 1995-09-12 | Tanox Biosystems, Inc. | Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils |
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
JP3156237B2 (ja) | 1991-12-24 | 2001-04-16 | 雪印乳業株式会社 | 抗ヒトIgE モノクローナル抗体 |
US6037453A (en) * | 1995-03-15 | 2000-03-14 | Genentech, Inc. | Immunoglobulin variants |
GB9908533D0 (en) * | 1999-04-14 | 1999-06-09 | Novartis Ag | Organic compounds |
WO2000072879A1 (en) | 1999-05-26 | 2000-12-07 | Tanox, Inc. | TREATING ALLERGIC DISEASES WITH IMMUNOTHERAPY AND IgE ANTAGONISTS |
-
2001
- 2001-03-28 SE SE0101093A patent/SE0101093D0/sv unknown
-
2002
- 2002-03-28 AU AU2002251624A patent/AU2002251624B8/en not_active Expired
- 2002-03-28 CA CA2441048A patent/CA2441048C/en not_active Expired - Lifetime
- 2002-03-28 EP EP02720698A patent/EP1373322A1/en not_active Ceased
- 2002-03-28 US US10/108,301 patent/US6986889B2/en not_active Ceased
- 2002-03-28 JP JP2002577880A patent/JP2005500992A/ja active Pending
- 2002-03-28 WO PCT/SE2002/000636 patent/WO2002079257A1/en active Application Filing
-
2010
- 2010-04-09 US US12/757,821 patent/USRE42324E1/en not_active Expired - Lifetime
-
2013
- 2013-08-09 JP JP2013166370A patent/JP2014012683A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2002079257A1 (en) | 2002-10-10 |
JP2005500992A (ja) | 2005-01-13 |
JP2014012683A (ja) | 2014-01-23 |
CA2441048A1 (en) | 2002-10-10 |
CA2441048C (en) | 2011-12-13 |
AU2002251624B2 (en) | 2008-09-04 |
EP1373322A1 (en) | 2004-01-02 |
US20030035796A1 (en) | 2003-02-20 |
US6986889B2 (en) | 2006-01-17 |
USRE42324E1 (en) | 2011-05-03 |
AU2002251624B8 (en) | 2008-10-02 |
AU2002251624A2 (en) | 2008-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0401601D0 (sv) | Protofibril specific antibodies and uses thereof | |
EA200400586A1 (ru) | Замещённые тиоацетамиды | |
HUP0102550A2 (hu) | IgE választ befolyásoló tulajdonságú vegyületek | |
EE200700052A (et) | Antikeha he v?i mitme apo-lipoproteiin B fragmendi vastu | |
ATE504315T1 (de) | Methode für die ausarbeitung von cd10-aktivierten prodrug-verbindungen | |
EA200201046A1 (ru) | 7- или 9-замещенные соединения тетрациклина, способ их получения (варианты), фармацевтическая композиция, способ лечения состояния, чувствительного к действию тетрациклина, у млекопитающего и реакционноспособное промежуточное производное | |
NO20030845D0 (no) | Utvalgte fusjonerte pyrrolokarbazoler | |
BR0214519A (pt) | Inibidores de fator xa e outras serina proteases envolvidas na cascata da coagulação | |
EA200300873A1 (ru) | Новая соль сукцинат o-десметилвенлафаксина | |
DE69927960D1 (de) | Epiallopregnanolon zur behandlung von krankheiten des cns | |
AT500379B1 (de) | Tau-proteine | |
DE60331598D1 (de) | Verabreichung von anti-tnf-alpha f(ab')2 antikörper-fragmenten | |
DE69433663D1 (de) | Antikörper gegen menschliches prostatspezifisches drüsenkallikrein | |
DK1636561T3 (da) | Kombinatorisk proteinbiblioteksscreening ved hjælp af periplasmatisk ekspression | |
HUP0401614A2 (hu) | PDE4 inhibitort és antikolinerg hatóanyagot tartalmazó gyógyszerkészítmények és alkalmazásuk | |
ATE373016T1 (de) | Induktion von immunologischer toleranz gegen einen therapeutischen antikörper durch varianten des therapeutischen antikörpers | |
NO20033220L (no) | Inhibitorer for cruzipain og andre cysteinproteaser | |
ATE312096T1 (de) | Neue verbindungen | |
EP1610678A4 (en) | ANTIBODIES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME USEFUL FOR INHIBITING METALLOPROTEIN ACTIVITY | |
EA200401081A1 (ru) | Fab-фрагменты моноклонального антитела человека, направленные против гликопротеина e2 hcv и обладающие нейтрализующей активностью in vitro | |
WO2003048207A3 (en) | Anti-dota antibody | |
DE50208918D1 (de) | 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung | |
HN2002000366A (es) | Anticuerpo que inhibe la actividad del factor de las celulas precursoras y su uso para el tratamiento del asma | |
SE0101093D0 (sv) | Novel compound for treatment of allergy and asthma | |
HUP0300142A2 (hu) | Humán LDL-receptorra specifikus monoklonális ellenanyagok, előállításuk és alkalmazásuk |